TY - GEN AU - Di Leo,A AU - Bajetta,E AU - Buzzoni,R AU - Bochicchio,A M AU - Nolè,F AU - Biganzoli,L AU - D'Aprile,M AU - Veltri,E AU - Comella,G AU - Aitini,E TI - Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group SN - 0277-3732 PY - 1995///0614 KW - Aged KW - Ambulatory Care KW - Bone Neoplasms KW - drug therapy KW - Drug Synergism KW - Drug Therapy, Combination KW - Epirubicin KW - administration & dosage KW - Heart Failure KW - chemically induced KW - Humans KW - Male KW - Medroxyprogesterone Acetate KW - Middle Aged KW - Neoplasms, Hormone-Dependent KW - Pain KW - Pain Measurement KW - Palliative Care KW - Prostatic Neoplasms KW - Survival Analysis N1 - Publication Type: Clinical Trial; Journal Article; Multicenter Study UR - https://doi.org/10.1097/00000421-199506000-00011 ER -